PharmaBoardroom

Biosimilars & Biologics: Singapore

A brief overview of the situation regarding biosimilars & biologics in Singaporean Pharma. Prepared in association with Drew & Napier LLC,…

Orphan Drugs & Rare Diseases: Singapore

The ins and outs of orphan drugs & rare diseases in Singaporean Pharma. Prepared in association with Drew & Napier LLC, this is an extract…

Cannabinoid Drugs, Medicinal Cannabis and Opioid Drugs: Singapore

Cannabinoid drugs, medicinal cannabis and opioid drugs in Singaporean Pharma - a legal guide. Prepared in association with Drew & Napier LLC,…

Joan Shen – CEO, I-Mab Biopharma

Dr Joan Shen, CEO of I-Mab Biopharma, shares her impressive career journey across companies like Pfizer, Janssen and Jiangsu Hengrui, before joining…

Desmond Hau – CEO, Pangenia Group

Dr Desmond Hau, CEO of Pangenia Inc, sits down with PharmaBoardroom to shed light on the company’s progress since taking the reins three years ago.…

Pharma Faces: Jorge Alderete, ALK Americas

Jorge Alderete, president of ALK Americas, recently spoke to PharmaBoardroom about his 20+ years with the Danish mid-cap, the challenges in…

The Moroccan Firms Bringing MNCs to Africa

Some of the more entrepreneurial Moroccan local laboratories have spotted an opening to leverage their knowledge of Sub Saharan African markets and to…

What Can Brazil’s Pharma Industry Learn from India?

The editorial team at Panorama Farmaceutico explain why coordinated action is needed within Brazilian pharma to reduce dependence on API imports from…

Understanding Cannabis Liberalization in Thailand

On February 19, 2019, by amending the Narcotics Act B.E. 2522, Thailand caught the cannabis industry by surprise and became the first Asia-Pacific…

Updates on Cannabinoid Regulation in Algeria

The ongoing reform of pharmaceutical regulations in Algeria has been marked on January 2020 by publication in the Official Gazette of the long-awaited…

China Pharma News Roundup May 25th 2020

A roundup of the latest news in Chinese pharma, including a US IPO for Burning Rock Biotech, positive news on CanSino’s COVID-19 vaccine trials, and…

What Can a Plasma ‘Alliance’ do for COVID-19?

A newly formed ‘Plasma Alliance’ of the world’s leading blood plasma companies believed that plasma from those who have recovered from COVID-19…

Tagged with